The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score 1.31 — grey zone — between safe and distressedWatch
- Earnings-manipulation signal · Beneish M -2.71 — no flag raisedOK
- Earnings quality 88/100 — accruals in line with cashOK
Where the revenue comes from
Fiscal 2025, as MARAVAI LIFESCIENCES HOLDINGS, INC. reports it. History and quarterly detail are in the app.
- TriLink$119.8M
- Cygnus$66.0M
Leadership changes
From MARAVAI LIFESCIENCES HOLDINGS, INC.'s own filings, the day they're filed.
- Rajesh Asarpota · Chief Financial Officer · appointmenteff. 2025-06-30
- Kevin Herde · Chief Financial Officer · appointmenteff. 2025-06-30
- Bernd Brust · Chief Executive Officer · departureeff. 2025-06-08
Latest filings
- 10-Q · Quarterly report2026-08-07
- 8-K · Company announcement2026-08-06
- 8-K · Company announcement2026-06-03
- 8-K · Company announcement2026-05-29
- 10-Q · Quarterly report2026-05-08
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about MARAVAI LIFESCIENCES HOLDINGS, INC., every answer cited to the official filings🔒
- The Intelligence Brief — added when MARAVAI LIFESCIENCES HOLDINGS, INC.'s brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.